New cap aims to stop deadly infections in dialysis patients
NCT ID NCT07019610
First seen Feb 28, 2026 · Last updated May 15, 2026 · Updated 12 times
Summary
This study tests whether a special cap containing chlorhexidine can prevent serious bloodstream infections in people receiving hemodialysis through a central line. About 60 adults with kidney failure will be randomly assigned to use either the standard cap or the new chlorhexidine cap. The main goals are to see if the study is feasible and if the new cap reduces infection rates.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATHETER-RELATED INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Royal Brisbane and Women's Hospital
Herston, Queensland, 4029, Australia
Conditions
Explore the condition pages connected to this study.